Page last updated: 2024-11-05

trifluperidol and Psychoses

trifluperidol has been researched along with Psychoses in 15 studies

Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)

Research Excerpts

ExcerptRelevanceReference
"About 30 patients with, in some cases, recurring paranoid or paranoid-hallucinatory psychoses underwent a long-term treatment--from 2--6 years according to individual cases--with very small doses of powerful neuroleptics (Haloperidol, Triperidol, and occasionally Trisedyl)."3.65[Neuroleptic long term care with extremely low doses in psychotic syndromes of paranoid-hallucination type]. ( König, L; Rossner, M, 1975)
"We report on a patient with schizoaffective disorder who was on combination therapy of lithium, carbamazepine, and the neuroleptic trifluperidol."1.30Persistent cerebellar deterioration in a patient with lobar pneumonia under lithium, carbamazepine, and trifluperidol treatment. ( Bischof, F; Fetter, M; Melms, A, 1999)

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-199014 (93.33)18.7374
1990's1 (6.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DELAY, J1
PICHOT, P1
LEMPERIERE, T1
BAILLY, R1
CATTAN, F1
BASQUIN, R1
DIPIAZZA, P1
GORI, EC1
LEVI-MINZI, S1
O'REILLY, PO1
O'REGAN, JB1
LIOANAG, EM1
FROGEL, M1
Braun, GA1
Paulonis, ME1
Bischof, F1
Melms, A1
Fetter, M1
Hornbeck, CL1
Griffiths, JC1
Neborsky, RJ1
Faulkner, MA1
Rossner, M1
König, L1
Fish, B1
Shapiro, T1
Campbell, M1
Wile, R1
Le Vann, LJ1
Tetreault, L1
Filotto, J1
Bordeleau, JM1
Marino, A1
Fink, M1
Simeon, J1
Haque, W1
Itil, T1
Gunby, B1
Steenfeldt-Foss, OW1

Trials

1 trial available for trifluperidol and Psychoses

ArticleYear
[Triperidol, a new psychopharmacon in the treatment of psychoses].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1966, Jul-15, Volume: 86, Issue:14

    Topics: Antidepressive Agents; Humans; Psychotic Disorders; Trifluperidol

1966

Other Studies

14 other studies available for trifluperidol and Psychoses

ArticleYear
[Triperidol and chemotherapy of psychoses].
    La Presse medicale, 1962, Oct-27, Volume: 70

    Topics: Humans; Mental Disorders; Psychotic Disorders; Tranquilizing Agents; Trifluperidol

1962
[CLINICAL EXPERIMENTATION WITH TRIPERIDOL].
    Rassegna di studi psichiatrici, 1963, Volume: 52

    Topics: Biomedical Research; Electromyography; Extrapyramidal Tracts; Hallucinations; Humans; Mental Disorde

1963
TRIPERIDOL (A PRELIMINARY REPORT).
    Diseases of the nervous system, 1964, Volume: 25

    Topics: Adolescent; Biomedical Research; Geriatrics; Mental Disorders; Parasympatholytics; Parkinsonian Diso

1964
[EFFECT OF DRUG THERAPY ON REHOSPITALIZATIONS AT THE BEL AIR CLINIC OF PATIENTS WITH CHRONIC PSYCHOSES EXCEPT MANIC-DEPRESSIVE PSYCHOSES].
    Psychiatria et neurologia, 1964, Volume: 147

    Topics: Bipolar Disorder; Chlorpromazine; Chlorprothixene; Convulsive Therapy; Drug Therapy; Haloperidol; Ho

1964
Sterol metabolism: biochemical differences among the butyrophenones.
    International journal of neuropsychiatry, 1967, Volume: 3

    Topics: Animals; Antidepressive Agents; Cholesterol; Haloperidol; Humans; Psychotic Disorders; Trifluperidol

1967
Persistent cerebellar deterioration in a patient with lobar pneumonia under lithium, carbamazepine, and trifluperidol treatment.
    European psychiatry : the journal of the Association of European Psychiatrists, 1999, Volume: 14, Issue:3

    Topics: Anti-Bacterial Agents; Antipsychotic Agents; Carbamazepine; Cerebellar Diseases; Disease Progression

1999
A gas chromatographic mass spectrometric chemical ionization assay for haloperidol with selected ion monitoring.
    Biomedical mass spectrometry, 1979, Volume: 6, Issue:10

    Topics: Adolescent; Adult; Ammonia; Gas Chromatography-Mass Spectrometry; Haloperidol; Humans; Male; Methane

1979
[Neuroleptic long term care with extremely low doses in psychotic syndromes of paranoid-hallucination type].
    Psychiatrie, Neurologie und medizinische Psychologie. Beihefte, 1975, Volume: 20-21

    Topics: Dose-Response Relationship, Drug; Hallucinations; Haloperidol; Humans; Long-Term Care; Paranoid Diso

1975
A classification of schizophrenic children under five years.
    The American journal of psychiatry, 1968, Volume: 124, Issue:10

    Topics: Aggression; Child, Institutionalized; Child, Preschool; Education, Special; Female; Follow-Up Studie

1968
A new butyrophenone: trifluperidol. A psychiatric evaluation in a pediatric setting.
    Canadian Psychiatric Association journal, 1968, Volume: 13, Issue:3

    Topics: Adolescent; Antidepressive Agents; Aspartate Aminotransferases; Attention; Brain Damage, Chronic; Bu

1968
Haloperidol and trifluperidol in psychiatry.
    Drug and therapeutics bulletin, 1968, Jul-19, Volume: 6, Issue:15

    Topics: Antidepressive Agents; Butyrophenones; Fluorine; Haloperidol; Humans; Piperidines; Psychotic Disorde

1968
[Neuroleptics and extrapyramidal effects: correlation between antipsychotic and extrapyramidal properties].
    Canadian Psychiatric Association journal, 1968, Volume: 13, Issue:6

    Topics: Antidepressive Agents; Butyrophenones; Chlorpromazine; Extrapyramidal Tracts; Female; Fluorine; Huma

1968
[Parkinsonian and neurodysleptic syndromes during treatment with neuroleptic drugs].
    Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali, 1965, Aug-31, Volume: 89, Issue:4

    Topics: Adolescent; Adult; Female; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease; Psychotic Diso

1965
Prolonged adverse reactions to LSD in psychotic subjects.
    Archives of general psychiatry, 1966, Volume: 15, Issue:5

    Topics: Adult; Chlorpromazine; Humans; Lysergic Acid Diethylamide; Male; Middle Aged; Psychotic Disorders; T

1966